Loading clinical trials...
Loading clinical trials...
A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RA-PRO Pragmatic Trial (RA-PROPR)
Conditions
Interventions
targeted synthetic DMARD class
non-TNFi-biologic class
Locations
49
United States
East Alabama Arthritis Center PC
Auburn, Alabama, United States
Bendcare, LLC
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
SunValley Arthritis Center, Ltd
Peoria, Arizona, United States
University of Arizona
Tucson, Arizona, United States
Pacific Arthritis Care Center
Los Angeles, California, United States
Start Date
September 22, 2021
Primary Completion Date
February 28, 2027
Completion Date
December 31, 2028
Last Updated
July 18, 2025
NCT06329401
NCT07484243
NCT06647069
NCT06841562
NCT07268326
NCT06599658
Lead Sponsor
University of Alabama at Birmingham
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions